Credo Therapies
Credo Therapies

Credo Therapies

Bringing evidence-based care to overlooked eating disorders

Binge eating and related disorders are among the most common – it’s a feature present in more than 80% of eating disorders. Yet it’s chronically under supported.

Credo Therapies is transforming care for non-restrictive eating disorders with a clinically validated, tech-enabled platform that delivers digitised psychotherapy. Built on decades of research at Oxford’s CREDO centre, their model is reaching people long left out of the system.

Sector
HealthTech
Stage
  • Pre-Seed/Seed
OSE Manager Limited, a wholly owned subsidiary of Oxford Science Enterprises plc, is authorised and regulated by the Financial Conduct Authority.